InQu® is the cell-friendly biosynthetic™ bone graft with proven clinical efficacy leading to faster bone fusion.
InQu’s composition of a resorbable polymer, PLGA, integrated with a biologic molecule, hyaluronic acid, creates a biosynthetic scaffold ideal for bone regeneration.
PLGA provides a biopolymer scaffold with a resorption profile tailored to match the rate of new bone formation.
Hyaluronic acid creates a cell-friendly microenvironment with a favorable pH, allowing InQu to bind up to 78% of MSCs within 20 minutes5.
InQu Bone Graft Extender & Substitute combines a biologic molecule with the consistency and cost effectiveness of a synthetic to create a new category of bone graft: Biosynthetic.
Clinically proven fusion rates of 94%, outperforming fusion rates for ICBG at 12 months1.
Integrated PLGA and hyaluronic acid creates a cell-friendly microenvironment, binding MSCs and growth factors 2,3
Demonstrated robust fusion, even in challenging high-risk patients.
Shorter time to fusion vs. traditional synthetic bone grafts AND superior overall fusion rates at 12 months: 93% vs. 68%4.
InQu offers a cost-effective, on-label solution for fusion throughout the spine.
A cohesive, moldable putty providing ease-of-use for a variety of applications.
InQu partners with the body’s natural processes to form bone in a shorter period of time without inciting an immune response. In contrast, traditional synthetics rely on inflammation and recruitment of specialized cells to digest the mineral scaffold before new bone formation can begin.
Cohesive putty available in 2.5cc, 5cc and 10cc sizes.
Available as 5x5cm and 5x10cm moldable strips.
Available in 30cc as a graft extender.
